
Deals ramp up in Asia’s healthcare space with cancer focus
An acquisition in Hong Kong by the New 正规官方授权/168澳洲5开奖查看历史记录大数据 Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.
May 28, 2024